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T.A. Alam,* A.M. Seifalian and D. BakerUniversity Department of Surgery, Royal Free and University College Medical School,
University College London and The Royal Free Hospital, London, UKAn intact vascular endothelium is critical to the maintenance of normal arterial tone and coagulation status. Endothelial
injury leading to dysfunction is thought to be a precursor to most if not all vascular disease, and has been implicated as a
critical event in atherosclerosis. At present there are several methods available for detection of in vivo endothelial function,
and the aim of this study was to critically review these methods. Five distinct methods were identified and studied in detail.
These methods are diverse and each assesses a different vascular bed. Importantly there is no uniformity among investigators
over choice of method and protocol, making it difficult to compare in vivo enothelial dysfunction between groups. These
issues need to be addressed in large scale comparative analyses so that investigators can agree a common approach to
endothelial function assessment.Keywords: Endothelium; Endothelial; Dysfunction; Nitric oxide; Smooth muscle; Cardiovascular disease; Venous occlusion
plethysmography; Flow-mediated dilatation; Iontophoresis; Coronory angiography; Microvascular; Artery.Introduction
An intact vascular endothelium is essential in main-
taining short term control of arterial tone and
coagulation status, and longer term control of smooth
muscle cell proliferation and extra-cellular matrix
production. Injury to the vascular endothelium is
likely to be a preliminary event in most if not all
vascular disease. Endothelial dysfunction has been
implicated in a wide range of diseases from diabetes
mellitus and essential hypertension, to vasospastic
conditions such as systemic sclerosis and primary
Raynaud’s phenomenon. Furthermore, it is postulated
that endothelial dysfunction is a precursor to frank
atherosclerosis;1–4 indeed it has been identified in vivo
in healthy individuals exposed to cardiovascular risk
factors such as cigarette smoking, obesity, increasing
age and male sex. Cardiovascular disease is currently
a leading cause of morbidity and mortality in theing author. T. A. Alam, Specialist Registrar in General
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impetus for the development of methods that facilitate
in vivo assessment of endothelial function. For many,
the long term goal is none other than the establishment
of a diagnostic tool that can detect disease early and
monitor therapeutic responses.
There are at least five distinct methodologies that
are currently being used for in vivo endothelial
function assessment (Table 1). Some methods, such
as venous occlusion plethysmography (VOP), are well
established and have been in use for many years, while
others are still at the developmental stage. Impor-
tantly, there appears to be very little uniformity among
investigators regarding method selection and proto-
col. The aim of this study, therefore, is to critically
review the methods currently being used for periph-
eral endothelial function assessment.Venous Occlusion Plethysmography
Venous occlusion plethysmography (VOP) has been
used to study forearm blood flow for many years. InEur J Vasc Endovasc Surg 29, 269–276 (2005)
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Table 1. Methods used for in vivo endothelial function testing
Technique Vascular bed Invasiveness Accuracy/reproducibility
Venous occlusion plethysmo-
graphy (VOP)
Forearm resistance vessels Moderately invasive Highly accurate and reprodu-




Brachial (conduit) artery Non-invasive Accuracy depends on quality
of equipment/software.
Observer variations an issue
Laser Doppler iontophoresis Forearm skin microvessels Non-invasive Conflicting reports. No clear
data as yet
Pulse wave analysis ‘Global’ endothelial function Non-invasive Unclear how accurately global
arterial stiffness reflects endo-
thelial function
Retinal arterial architecture Retinal arterioles Non-invasive Not yet assessed
T. A. Alam et al.270fact, it was first described in 1909 by Hewlett and van
Zwaluwenburg,6 and aside from the incorporation of
computer technology, the method has remained
essentially unchanged since then. The underlying
principle involves the arrest of venous outflow from
the forearm such that it begins to swell. The rate and
degree of swelling reflects forearm vascular resistance,
which is a function of normal vascular endothelial
function.
The method is widely used, with most practitioners
using the protocol established by Wilkinson and
Webb.7 When performing the procedure it is critical
that baseline vasomotor tone remains constant, so
factors which may affect vasoreactivity are carefully
avoided. Thus, VOP is performed in a quiet, tempera-
ture-controlled room, with the subject relaxing in a
reclining position. Subjects are asked to abstain from
fatty meals, alcohol, caffeine and tobacco in the
preceding 6 h. Blood pressure cuffs are placed around
the arm and around the wrist, and the arm is held
above the level of the heart. The arm cuff is inflated just
enough to occlude venous outflow while preserving
arterial inflow (around 40 mmHg), and the hand is
excluded from the circulation by inflating the wrist
cuff to supra-systolic pressures (200 mmHg). As the
isolated forearm begins to swell, forearm volume,
measured by a voltage dependent strain-gauge,
increases in direct proportion to forearm blood flow.
The hand is excluded because it’s blood flow is highly
temperature sensitive, and it contains a high pro-
portion of arterio-venous shunts. A degree of hand
ischaemia is inevitable, and limits the testing period to
usually no more than 10 min. Both arms are usually
studied at the same time, the contra lateral arm
providing a contemporaneous control.7 The increase
in forearm volume is taken to represent blood flow in
the resistance vessels of the forearm (muscle, soft
tissues and skin).
VOP provides a convenient platform for testing
forearm vascular resistance. In turn, vascularEur J Vasc Endovasc Surg Vol 29, March 2005resistance can be readily manipulated by administer-
ing vasoactive drugs directly into the brachial artery
using a small (27 G) cannula. Changes in vascular
resistance reflect endothelial function. Investigating
pharmacological effects in a closed circuit in this
fashion has the advantage of avoiding systemic
infusions of potentially dangerous drugs, and
although there is a theoretical risk of critical forearm
ischaemia when investigating vasoconstrictors, this is
seldom seen in practice. Complications arising from
repeated brachial arterial cannulation are rare,8 never-
theless the procedure should be regarded as moder-
ately invasive.
Over the years, VOP has proved itself to be a robust
and reliable tool for the investigation of vascular
function. Despite an image of being cumbersome and
somewhat dated, the procedure is well tolerated and
continues to be popular. Using intra-arterial infusions
of acetylcholine and sodium nitroprusside, VOP has
been used to associate endothelial dysfunction with a
range of cardiovascular risk factors such as smoking,
hypertension, diabetes and aging.9–14 Most authors
have found good reproducibility,15,16 and some even
regard the technique as the ‘gold-standard’ for the
assessment of vascular function.7,17Brachial Artery Flow-mediated Dilatation
Blood vessels have the capacity to adjust blood flow in
response to luminal physical and chemical stimuli.
This ability to self-regulate vasomotor tone allows the
vessel to respond to changes in the local environment.
An increase in blood flow will result in an increase in
the ‘shear stress’ to which the local vascular endo-
thelium is subjected and the vessel responds by
dilating, a phenomenon called flow-mediated vasodi-
latation (FMD)1,18–20 Using a high resolution ultra-
sound scanner, it is possible to monitor and record
Assessment of In vivo Endothelial Function 271changes in vessel diameter resulting from FMD, and
thus non-invasively determine endothelial function.
FMD is measured in conduit arteries, usually of a
diameter between 2.5 and 5 mm, and the brachial
artery is a convenient choice. The size of the vessel is
an important consideration; if too small then it will be
technically difficult to obtain accurate and reproduci-
ble images, whereas if too big then vasodilatation may
be difficult to perceive, even when endothelial func-
tion is normal.21 A high-resolution ultrasound scanner
with a high-frequency vascular transducer and an
internal ECG monitor is required. The scanner must be
equipped with appropriate vascular software for 2-D
imaging, colour and spectral Doppler. Subjects are
examined supine, with the arm held in a comfortable
position, and care must be taken to avoid vasoreactive
factors. The brachial artery is examined in the
longitudinal plane above the antecubital fossa (Fig.
1). It is essential that a steady image of the artery is
maintained throughout the study, and the relative
position of anatomic landmarks such as veins and
fascial planes are noted.22
A blood pressure cuff, placed either above or below
the transducer position, is used to create the flow
stimulus in the brachial artery. When placed above, the
stimulus is greater, but accurate visualisation is more
difficult. After a baseline diameter measurement, the
cuff is inflated to a suprasystolic pressure for 5 min.
Cuff deflation induces a brief high flow state (reactive
hyperaemia) that subjects the endothelium to shear
stress causing it to dilate. This is said to be to be
endothelium-dependent vasodilatation. FMD is calcu-
lated as the percentage increase in diameter from
baseline to maximum post-cuff deflation diameter.
After a 10 min rest period, the artery returns to the
baseline diameter, at which point sublingual glycerylFig. 1. Photograph depicting armrest with ultrasound probe
locked in place over brachial artery and occluding blood
pressure cuff placed over upper arm.trinitrate (GTN) is given. The maximum diameter after
GTN reflects smooth muscle integrity (endothelium-
independent vasodilatation) and is theoretically the
maximum vasodilator response.
While some investigators have found the technique
to be both accurate and reproducible,4 others have not
been so impressed.2,3 There is no doubt that FMD is
vulnerable to criticisms of reproducibility, and intra/
inter-observer variability. An International Brachial
Artery Reactivity Task Force has been appointed, and
steps to investigate and minimise these problems are
underway.22 Ultrasonographic assessment of the bra-
chial artery is uniquely challenging and the examin-
ation must be performed by well trained, skilled
individuals. There is a significant learning curve, and
once sufficiently trained, sonographers must continue
to perform the technique on a regular basis to maintain
their skills. Ergonomic factors are also important, with
both examiner and subject assuming comfortable
positions, such that the transducer remains steady at
the same anatomical position throughout. This may
seem straightforward, but is actually quite a technical
challenge, and the use of a stereo tactic probe holding
device has been advocated22 (and should probably be
considered mandatory). Even when excellent images
of the brachial artery are obtained, off-line diameter
measurement using ultrasound callipers is not
reliable, and should be regarded as out of date. Some
investigators now use radio-frequency processing
software, as this facilitates accurate on-line tracking
of the anterior and posterior arterial walls.23 To
account for diameter changes associated with the
cardiac cycle, the signal must be ECG gated. Systems
of this type can give a theoretical accuracy of the
order of 5 m, although this is highly dependent on the
quality of the image.24
The theory and methodology behind FMD
measurement is now well established, and most
vascular laboratories are already equipped with the
necessary hardware. One can anticipate improve-
ments in the technique in parallel with advances in
imaging technology and computer software; for
example, phase-contrast magnetic resonance angio-
graphy has been advocated as an alternative to high-
resolution ultrasound. Although this may prove
superior in detecting minute vessel diameter changes,
at present ultrasound is preferred as it is more
dynamic (and cheaper).Iontophoresis in Conjunction with Laser Doppler
Imaging
Laser doppler iontophoresis (LDI) is a convenient andEur J Vasc Endovasc Surg Vol 29, March 2005
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minute quantity of a drug, using small electric
currents. The underlying principle is that the mol-
ecules of a drug in solution are either positively or
negatively charged, and will migrate across the skin
under the influence of an applied monopolar cur-
rent.25 The rate and quantity of drug delivered is
dependent on the magnitude of the applied current
and it’s duration:26current (Amps)!time (seconds)Zcharge
(Coulombs).
This method of drug delivery is not new, and has
been in use for over 20 years.27 However, it has only
recently become apparent that, when used in conjunc-
tion with laser Doppler flowmetry, it is a useful tool for
monitoring microvascular endothelial function.28 The
procedure involves time-controlled delivery of a
vasoactive drug onto a patch of skin on the subjects
forearm. The resultant alterations in skin blood flow
are then detected using laser Doppler flowmetry, or
more recently using a laser Doppler imager.25 Laser
Doppler imaging allows blood flow measurement
over the entire distribution of the administered drug,
whereas laser Doppler flowmetry restricts blood flow
measurements to single points in the distribution. The
alterations in blood flow reflect endothelial function at
a microvascular level. A typical equipment set up is
shown in diagrammatic form in Fig. 2.
Acetylecholine and sodium nitroprusside are used
to generate endothelium-dependent and endothelium-
independent vasodilatation, respectively. The pro-
cedure is carried out using very small currents (less
than 100 mA), and is painless. The forearm micro-
vascular bed is usually the site of choice, and
iontophoretic electrodes are attached to the volar
aspect. The quantity of drug delivered is too small to
have any systemic effects, although mild allergic
reactions and skin irritation have been reported.29
The procedure is performed in similar conditions to
those described for VOP and FMD, taking care to
avoid factors that may induce vasoreactivity.
LDI is an attractive technique, but there are several
important problems that must be overcome. The
variability of skin conductivity in different popu-
lations must be considered when designing studies
and interpreting results. While Ohm’s Law has been
used to correct for these differences, one could argue
that applying such physical laws to organic tissue
adds a spurious air of accuracy. Although the
procedure is short (typically 15 min), subjects are
required to remain entirely still during that time, withEur J Vasc Endovasc Surg Vol 29, March 2005the forearm held in supination; this may result in
movement artefacts owing to subject fatigue.
A more significant problem is the tendency of the
applied current itself to cause vasodilatation, even in
the absence of an administered drug. The precise
aetiology of current-induced vasodilatation is complex
and has yet to be fully defined. It has been well
documented that this phenomenon is more pro-
nounced with cathodal (acetylcholine) rather than
anodal (sodium nitroprusside) drug delivery.29–33
Some investigators have postulated that primary
afferent nerves, specifically C-nociceptive fibres, may
have an important role.30,33 Neurovascular responses
are thought to be directly stimulated by the applied
current, resulting in the release of vasodilatory
neuropeptides, such as calcitonin gene-related peptide
and substance P. The most effective way of limiting
current-induced vasodilatation seems to be the use of
smaller currents over longer time-periods. The total
charge (and drug dose) delivered remains the same,
but stimulation of the neurovascular response is less
pronounced.
LDI is becoming increasingly popular, and with
good reason. It is non-invasive, provides a direct
assessment of microvascular endothelial function, and
the technique is resistant to accusations of observer
dependency. Reproducibility should not be a problem
if precautions, such as strict standardization of the
recording site, are taken.34Pulse-wave Analysis
LDI and FMD detect endothelial dysfunction in local
vascular beds, either skin microvasculature or the
brachial arterial tree. Pulse-wave analysis is a rela-
tively new technique that provides a non-invasive
method of assessing global endothelial function.35,36
Arterial stiffness is partly dependent on vasomotor
tone,37 which in turn relies on an intact endothelium.
As the arterial pulse waveform travels from the central
circulation to the periphery, it’s shape provides a
measure of systemic arterial stiffness,38 thus changes
in the shape of the waveform will partly reflect
endothelial function. The waveform is readily
observed at the radial artery by applanation tonome-
try.35 The arterial pulse waveform is reflected from the
periphery back to the central circulation,39 and this
may confound the observed radial waveform. To
account for this, endothelial function is assessed by
changes in the augmentation index (AIx), which is a
function of the relationship between the reflected
arterial wave and the primary aortic wave.39–41 In
essence, AIx provides a measure of systemic arterial
Fig. 2. Typical equipment set up for laser Doppler iontophoersis.
Assessment of In vivo Endothelial Function 273stiffness, and several studies have used it as a
surrogate marker for endothelial function.35,36,40,42
Endothelium-dependent vasodilatation is assessed
following inhalation of the b2-adrenergic receptor
agonist salbutamol, which has been shown to cause
the release of endothelium-derived vasodilator nitric
oxide.43 Endothelium-independent vasodilatation is
assessed following intravenous administration of
GTN.
The technology required for PWA is easily available
and relatively cheap, and it is relatively immune to
criticisms of observer dependency. But the procedure
is still at an early developmental stage and is not
widely used. Also, more work needs to be done
to clarify whether AIx is a consistently reliableparameter. Those with high cardiovascular risk or
established atherosclerotic disease may exhibit differ-
ent wave reflection characteristics from the groups
studied thus far. Similarly, baseline cardiac parameters
may preclude certain patients from study. A high
resting heart rate, for example, may have an indepen-
dent association with arterial stiffness.44 In fact, the
precise association between arterial stiffness and
endothelial function has yet to be elucidated.Retinal Arterial Abnormalities
Abnormalities of architecture in an arterial network
can reflect generalised circulatory efficiency. The retinaEur J Vasc Endovasc Surg Vol 29, March 2005
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is possible to make non-invasive, in vivo assessments
of arterial architecture. The presence of abnormalities,
such as focal and generalised narrowing, arteriove-
nous nicking, altered arteriole to venule ratio, and sub-
optimal arterial diameter at bifurcations, can be
suggestive of a more generalised circulatory dis-
order.45–47 It has been reported, most notably by the
atherosclerosis risk in communities (ARIC) study, that
abnormalities in retinal arterioles are related to the
presence of carotid plaque, hypertension, and serum
markers of inflammation and endothelial function
such as von Willebrand Factor.46,47 Although it has
been reported that inhibition of endothelium-derived
nitric oxide synthesis by the nitric oxide synthase
antagonist NG-monomethyl-L-arginine (L-NMMA)
induces changes in junction exponents in human
retinal arteries,48 a precise correlation between per-
ipheral endothelial dysfunction and retinal arterial
abnormalities has yet to be made. A correlation has,
however, been made between the presence of periph-
eral vascular disease and retinal arteriolar
abnormalities.48
The retinal arteriolar network can be assessed using
non-invasive scans, which are then assessed by trained
individuals, assisted by computer software. The
concept of a simple retinal scan providing important
information about cardiovascular risk in individuals is
highly attractive. There seems no doubt that estab-
lished cardiovascular disease, probably with wide-
spread haemodynamic impairment, could be reflected
in retinal arterial architecture. However, as far as we
are aware, no group has yet demonstrated that
generalised endothelial dysfunction per se, can result
in retinal arterial abnormalities.Clinical Impact
Of the methods described in this review, by far the
most widely used are VOP, FMD and LDI. Each one of
these methods assesses endothelial function in a
different vascular bed, and they vary in their degree
of invasiveness (VOP, requiring arterial cannulation
should be regarded as more invasive than either FMD
or LDI). The choice of which method to use is largely
governed by local knowledge and equipment avail-
ability, and there is as yet no data to suggest that any
particular method should be used in any particular
study. An important question is—does endothelial
dysfunction in one vascular bed correlate with
endothelial function in other vascular beds in the
same subject group?
Several investigators have attempted to answer thisEur J Vasc Endovasc Surg Vol 29, March 2005question, but their reports are conflicting. In a some-
what limited study of six healthy subjects compared to
10 hypertensive/obese individuals, Irace et al.49
reported a high correlation of endothelial function
(p!0.001) between FMD and VOP. However, Lind et
al.50 evaluated both these methods in 24 healthy
subjects, and did not find any correlation. Raitakari
et al.21, in their study of post-prandial endothelial
function, noticed a significant change with VOP, but
not with FMD (p!0.001;nZ12). Similar studies com-
paring FMD and LDI also fail to demonstrate a
significant correlation in endothelial function in these
vascular beds.51,52 PWA has been widely used to study
arterial stiffness, but it’s use for endothelial function
testing is still limited. However, comparisons between
PWA and VOP appear to be quite favourable, as
confirmed by Lind et al.50, and also by Wilkinson et al.
36
Perhaps the most compelling question is—can any
of these methods be used in individuals as a screening
tool for cardiovascular disease? Alas, at present the
answer appears to be no. The very nature of
endothelial function testing makes it incompatible
with good reproducibility in individuals, because it’s
extremely difficult to reliably control all potentially
vasoreactive influences at all times. Furthermore,
some of the methods described (such as FMD) are
inherently prone to observer error. However, these
methods are useful when studying the effect of a single
risk factor or condition on a group of individuals.
Thus, more work is required to inform future
investigators on the appropriate choice of method/-
protocol, and there needs to be a better degree of
uniformity so that findings are easily compared.Acknowledgements
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